ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

2023 AHA CME Symposium - Translating Clinical Trials to Clinical Practice: Improving HF Outcomes with Intravenous Iron

By: PRLog

This CME Symposium takes place during the 2023 American Heart Association (AHA) Scientific Sessions on Sunday, November 12, 2023 from 7:00 PM - 8:30 PM ET at Philadelphia Marriott Downtown Ballroom, Philadelphia, Pennsylvania.

HAZLET, N.J. - Oct. 18, 2023 - PRLog -- In this program, experts in iron deficiency in HF will explain the pathophysiology of iron deficiency in HF, specifically the role of hepcidin in hyperinflammatory states (such as HF) and subsequent implications on iron supplementation approaches. The prognosis of comorbid iron deficiency and HF will be described, and appropriate, timely patient screening and diagnostic testing of serum ferritin and transferrin saturation (TSAT) will be emphasized based on expert-generated algorithms. A multidisciplinary panel will appraise recently released clinical data of IV iron therapies for iron deficiency in HF and translate the information into "real-world" clinical practice.

Click here for more information

CHAIR

Robert Mentz, MD
Associate Professor of Medicine
Associate Professor in Population Health Sciences
Duke University School of Medicine
Durham, North Carolina

FACULTY

Nancy M. Albert, PhD, CCNS, CHFN, CCRN, NE-BC
Associate Chief Nursing Officer—Research and Innovation
Clinical Nurse Specialist—Kaufman Center for Heart Failure
Cleveland Clinic
Cleveland, Ohio

Stefan Anker, MD, PhD
Professor of Cardiology & Metabolism
Department of Cardiology
BCRT and German Centre for Cardiovascular Research
Charité Universitätsmedizin
Berlin, Germany

Katherine E. Di Palo, PharmD, MBA, MS
Senior Director, Transitional Care Excellence
Assistant Professor of Medicine
Albert Einstein College of Medicine
Bronx, New York

Adrian F. Hernandez, MD, MHS
Professor of Medicine and Vice Dean
Duke University School of Medicine
Executive Director, Duke Clinical Research Institute
Durham, North Carolina

This educational activity is intended for cardiovascular clinicians.

Voxmedia International gratefully acknowledges the independent educational grant provided by American Regent.

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Voxmedia LLC designates this activity for a maximum of 1.5 AMA PRA Category Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1.5 Credits™ through its reciprocity agreements.

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

This is a complimentary event. Registration does not guarantee seating. This event is designed for the education of clinicians and improvement in the care of patients according to guidelines for care. Priority is given to clinicians. We are unable to accommodate guests.
For additional CME/CE activities visit www.CMEPlanet.com #cme #cmeplanet #clinical #HF

Contact
Voxmedia
***@voxmedia.us

Photos: (Click photo to enlarge)

Voxmedia Logo 2023 AHA CME Symposium


Source: CMEPlanet

Read Full Story - 2023 AHA CME Symposium - Translating Clinical Trials to Clinical Practice: Improving HF Outcomes with Intravenous Iron | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.